跳至主要内容
临床试验/CTRI/2019/12/022302
CTRI/2019/12/022302已完成未知

A clinical study to evaluate the efficacy of Aparajit Avaleha in the management of Vataja Kasa in children

Department of Kaumarbhritya0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of Vataja Kasa with symptoms Parshavshool, Shirashool, Urashool, Sawarbheda, Shuska Mukha and Gala as a major symptoms.
  • 2.Acute Cough of less than 7 days.
  • 3.Newly diagnosed cases of Vataja Kasa.

排除标准

  • 1.Patients below age of 6 years and above age of 12 years.
  • 2.Patients with chronic debilitating disease or disorders.
  • 3.All types of Kasa except Vataja Kasa Lakshana will be excluded.
  • 4.Conditions like Pneumonia, Juvenile Diabetes Mellitus, Tuberculosis, Bronchiolitis, Asthma < Chronic Productive Cough, Whooping Cough, Sinusitis, Tonsillitis should be excluded.
  • Cough with High Grade Fever.
  • 5.If Cough aggravates during treatment then it will be excluded.

研究者

发起方
Department of Kaumarbhritya

相似试验